Psoriasis linkage to 4q28-32 (PSORS9) was initially identified by our genome-wide scan in 61 Chinese families and subsequently supported by a meta-analysis of five genome-wide linkage scans of European populations. In this study, we performed a follow-up analysis of PSORS9 using an additional 90 families and improved marker coverage. Joint analysis of all 151 families obtained significant linkage evidence (HLOD ¼ 4.53, nonparametric linkage (NPL) ¼ 4.03 (P ¼ 0.000003)) at the marker interval D4S2997-D4S3033, and the same was obtained for the analysis of the independent new families (HLOD ¼ 4.33, NPL ¼ 3.15 (P ¼ 0.00004)). The linkage evidences from the whole families and the new families exceeded the genome-wide criteria for significant linkage. Furthermore, by performing an ordered subset analysis using mean age at onset as a covariate, we demonstrated that evidence for linkage to PSORS9 is concentrated in the early-onset families and suggested that further study of PSORS9 should focus on early-onset patients. This finding is contradictory to what was found in the Icelandic population and, together with other linkage results, suggests that Chinese and European populations are genetically different for linkage to PSORS9, which may partially explain the influence of ethnic factors on the varying prevalence of psoriasis.
INTRODUCTION
Psoriasis (OMIM*177900) is a common, immunologically mediated and hyperproliferative skin disease characterized by strong familial aggregation (Elder et al., 1994) , which has a worldwide distribution with prevalence varying according to race and geographical location (Christophers, 2001) . The estimated prevalence of psoriasis is 2-5% in the Caucasian population (Nevitt and Hutchinson, 1996) and 0.1-0.3% in the Far East (Simons, 1949; Yui, 1984) . In China, psoriasis affects 0.123% of the population and there have been more than 3 million cases reported since 1984 (Shao, 1996) . The influence of ethnic factors is particularly evident when one compares prevalence rates within the United States where the prevalence in the black population is far lower than that in the remainder of the population (Kennney, 1971; Schon and Boehncke, 2005) . Such ethnic factors are still poorly understood, and genetic difference between ethnic populations could play a role, as psoriasis is a genetically heterogeneous disease.
PSORS9 locus at 4q28-32 was initially suggested by our genome-wide scan in 61 Chinese Han families with psoriasis (Zhang et al., 2002) . Before our study, eight genome-wide linkage scan studies had been performed in psoriatic families of European populations (Tomfohrde et al., 1994; Matthews et al., 1996; Nair et al., 1997; Trembath et al., 1997; Capon et al., 1999; Samuelsson et al., 1999; Lee et al., 2000; Veal et al., 2001) , but linkage evidence at the PSORS9 locus was never strong enough to be reported. Intriguingly, a subsequent meta-analysis of the linkage results from five of these genome-wide linkage scans provided strong supporting evidence for PSORS9 (Sagoo et al., 2004) . More recently, by stratifying their psoriatic families of the Icelandic population according to age at onset (AAO), Karason et al. (2005) reported an LOD score of 3.6 at PSORS9 locus in the psoriatic families of late-onset, but the analysis of their whole family sample yielded very moderate evidence (LOD less than 1.5). Their results provided further evidence for AAO to be a surrogate marker of genetic heterogeneity in psoriasis, as suggested in previous studies (Raychaudhuri and Gross, 2000; Ferrandiz et al., 2002; Stuart et al., 2002) .
In this study, we performed a follow-up study of the PSORS9 locus using an expanded sample of 151 Chinese psoriatic families. Our linkage analysis of all 151 families as well as the independent sample of the 90 families provided confirmative evidence for linkage and refined the PSORS9 locus to a small region at 4q31-32. Furthermore, we performed an ordered subset analysis (OSA) using AAO as a covariate and clearly demonstrated that evidence for linkage to PSORS9 locus is concentrated in the families of early-onset psoriasis in the Chinese population.
RESULTS

Linkage analysis in 151 families
To improve marker coverage, seven additional microsatellite markers were selected within the region (between D4S1575 and D4S2979) surrounding the original linkage peak of our genome-wide scan at the PSORS9 locus (Zhang et al., 2002) . Together with six markers used in our genome-wide scan analysis within this region, 13 microsatellite markers (D4S1575, D4S2972, D4S2939, D4S420, D4S424, D4S2981, D4S3008, D4S413, D4S2997, D4S3033, D4S3046, D4S620, and D4S2979) were analyzed in this study providing dense marker coverage of about 3 cM per marker around the PSORS9 locus. The map positions of the 13 markers were determined according to the genetic map at the Marshfield (http://www.marshmed.org/genetics). Multipoint marker information content within the region, as evaluated by using the Hidden Markov Model implemented in GENEHUNTER (Rijsdijk and Sham, 2002) , was improved from 76.5 to 93.1% by adding the seven new markers.
We first performed a joint linkage analysis of the 61 original and 90 new families. Multipoint parametric analysis yielded a highly significant heterogeneity LOD (HLOD) score of 4.53 (a ¼ 45%) at the marker interval D4S2997-D4S3033, which was supported by a highly significant nonparametric linkage (NPL) score of 4.03 (P ¼ 0.000003) at the same marker interval (Figure 1 and Table 1 ). Both the multipoint HLOD and NPL scores exceeded the genome-wide criteria for significant linkage evidence (Lander and Kruglyak, 1995) . Two-point linkage analysis also provided supportive evidence, although LOD scores were less significant. The highest two-point HLOD score was 3.59 obtained at marker D4S413, and supportive LOD scores were also obtained at four surrounding markers (out of 13 markers): 1.95 at D4S2981, 3.14 at D4S3008, 3.11 at D4S2997, and 1.32 at D4S3033.
We then performed the linkage analysis by using the 61 original and 90 new families separately. The overall patterns of linkage evidence from the 61 original and 90 new families were very similar to that from all 151 families (Figure 1 ). The analysis of the 61 original families yielded a multipoint NPL score of 2.65 (P ¼ 0.004) and HLOD score of 1.12 at the marker interval D4S2997-D4S3033 (Figure 1 ). These LOD scores were less significant than the ones reported in our previous genome-wide scan study (Zhang et al., 2002) , probably due to the fact that more markers were analyzed and an affected-only analysis was performed in this study. The analysis of the 90 new families yielded a multipoint NPL score of 3.15 (P ¼ 0.00004) at the marker interval D4S2997-D4S3033 and a multipoint HLOD score of 4.33 (a ¼ 69%) at the marker interval D4S413-D4S2997 ( Figure 1 and Table 1 ).
OSA using mean AAO as a covariate OSA of all 151 families obtained a maximum OSA-LOD score of 4.24 at the marker interval D4S413-D4S2997 in a subset of 31 families whose mean AAO are up to 16.33 years old. Based on permutation testing with 10,000 replicates, this OSA-LOD score as well as the corresponding subset of 31 families is statistically significant with an empirical P-value of 0.020. Subsequent multipoint parametric analysis of the same 31 families obtained a highly significant homogeneity LOD score of 4.18 at the marker interval D4S413-D4S2997 (Table 1) , which is remarkably higher than the homogeneity LOD score of À17.0 obtained from all 151 families. The highly significant multipoint homogeneity LOD score was supported by significant two-point homogeneity LOD scores within the same genetic region: 3.12 at D4S2997, 3.05 at D4S413 and 1.18 at D4S3008. A highly significant HLOD score of 4.59 (a ¼ 92%) was also obtained at the same marker interval in the 31 families, whose a-value of 92% is Original families www.jidonline.org 313 substantially higher than the a-value of 45% of the HLOD score from all 151 families (Table 1) .
We also performed linkage analysis using the remaining 120 families whose mean AAO was above 16.33 years. The maximum NPL and HLOD scores from the 120 families were 2.80 (P ¼ 0.0009) and 1.84, respectively. These LOD scores were much less significant than the ones from all 151 families and the 31 families.
Defining the critical region of PSORS9
We estimated the 1-LOD-down supporting interval of PSORS9, a commonly employed approach for defining the critical region of linkage locus harboring the underlying susceptibility gene. Based on the parametric HLOD score result from all 151 families, the estimated supporting interval is about 7 cM flanked by markers D4S3008 and D4S3033 (Table 1) . Based on the homogeneity LOD score result from the identified ordered subset of the 31 families, the estimated supporting interval is about 5.5 cM flanked by the same markers D4S3008 and D4S3033. We also estimated the critical region of PSORS9 locus using GENEFINDER analysis, a general multipoint linkage method for estimating the chromosomal position of a putative susceptibility locus based on the identical by descent sharing of affected relative pairs (Glidden et al., 2003) . The results from GENEFINDER analysis were very similar to the above 1-LOD-down supporting intervals (data not shown).
DISCUSSION
Compared to our previous genome-wide scan study, the power of this follow-up study is greatly improved. First, we have greatly increased our sample size to 151 families by including an additional 90 new Chinese families with psoriasis in the follow-up study. Second, the marker coverage around the PSORS9 locus has also been considerably improved by adding seven additional markers so that almost all the meioses for linkage analysis were informative in this study as indicated by the very high marker information content of 93% within the region studied. The current follow-up study was also improved by employing an affectedonly approach for parametric linkage analysis. Although the affected-only analysis is generally considered to be conservative in identifying linkage, its linkage evidence is more convincing owing to its origin of evidence primarily from affected familial members and its decreased dependence on the maximization of the linkage evidence overpenetrance rate.
This follow-up study provided confirmative evidence for the linkage to the PSORS9 locus. By analyzing 13 markers in 151 families, we obtained highly significant parametric and nonparametric LOD scores at the PSORS9 locus. Furthermore, our analysis of the independent sample of the 90 new families also obtained highly significant linkage evidence. Both the LOD scores from all 151 families and from the 90 independent families exceeded the genome-wide criteria for significant linkage evidence. Therefore, our follow-up analysis of the 151 psoriatic families provided confirmative evidence for the PSORS9 locus, and more importantly, the highly significant linkage evidence from the analysis of the independent sample of the 90 new families constitutes a validation of our original linkage finding at the PSORS9 locus. Our confirmation is likely owing to the fact that the PSORS9 locus plays a major role in Chinese families of psoriasis and that both the original and new families were recruited from the same clinics using the same diagnosis criteria so that sample heterogeneity between the original genome-wide and the follow-up validation studies has been kept minimal. We further investigated the possibility of AAO to be a surrogate marker of genetic heterogeneity of psoriasis using the OSA analysis. OSA analysis is a recently developed statistical method to identify a homogeneous subset of families that contributes to overall linkage at a given chromosomal location and thus to potentially help in the fine mapping and localization of a susceptibility gene within a chromosomal area (Hauser et al., 2001 (Hauser et al., , 2004 Shao et al., 2003) . One major advantage of OSA analysis is that it does not require defining a priori cutoff value to divide the sample into phenotypic subsets as performed in conventional stratified linkage analysis. Unless a priori evidence for defining a suitable cutoff is clear, choosing a particular cutoff value of a disease-associated trait for stratifying families is quite arbitrary, which makes it difficult to evaluate the statistical significance of linkage results derived from such arbitrarily defined subsets of families. Furthermore, the permutation procedure of the OSA analysis allows a direct evaluation of the significance of the linkage evidence from subgroup analysis and thus the defined subset of families by calculating empirical P-values.
Our OSA analysis provided some interesting findings and important implications for future study of PSORS9. First, the OSA analysis identified a remarkable homogeneous subset of families for linkage to PSORS9, as suggested by the high homogeneity LOD score associated with the family subset. The identified subset includes 31 families whose mean AAOs are up to 16.33 years old, which is interestingly very similar to the AAO value commonly used for defining pediatric-or early-onset psoriasis. Associated with AAO at adolescence, the pediatric form of psoriasis had long been recognized and shown to have a higher female/male ratio, frequency of positive family history, and frequency of carriage of the HLA-associated psoriasis risk than that of adult patients (Melski and Stern, 1981; Henseler and Christophers, 1985; Raychaudhuri and Gross, 2000) . Psoriasis patients had also been characterized into early-and late-onset cases using a different AAO cutoff value of 40 years old, and the earlyonset patients were shown to be associated with a higher frequency of positive family history and Cw6 carriers, higher relative risk for first-degree relatives and more extensive skin involvement (Elder et al., 1994; Ferrandiz et al., 2002; Stuart et al., 2002) . Although they used different AAO values for defining early-and late-onset diseases, these studies did suggest that early-and late-onset psoriases are probably two genetically distinguishable groups of patients. The results from our OSA analysis provided supporting linkage evidence for such a suggestion and further indicated that AAO at adolescence is a good value to characterize early-and lateonset diseases, at least for defining more homogenous samples for genetic analysis of the PSORS9 locus.
Second, our result of the OSA analysis is surprisingly contradictive to what was found by Karason et al. (2005) in the Icelandic population. Karason et al. (2005) found that only the Icelandic families of late-onset psoriasis provided supporting evidence for linkage to PSORS9, whereas our result of OSA analysis clearly suggested that evidence for linkage to PSORS9 is concentrated in the Chinese families of early-onset psoriasis. In the Karason et al. (2005) study, a traditional method for stratified linkage analysis was employed by first choosing an a priori AAO cutoff value of 17 to divide the whole family sample into early-and late-onset families and then performing linkage analysis in each subset of families, which is quite different from the OSA analysis performed in this study as discussed above. Although the possibility cannot be totally ruled out, we argue that such a striking difference in linkage result between these two studies is less likely due to the methodological difference in performing stratified linkage analysis between two studies. We suggest that the difference may represent evidence for genetic heterogeneity between ethnic populations in terms of linkage to PSORS9. Such a suggestion is consistent with the previous linkage findings in European populations that reported very weak, if any, supporting evidence for PSORS9, while the supporting evidence only emerged after the results of these five studies were pooled together in a meta-genomescan analysis. Although the supporting linkage result of the meta-genome-scan analysis did indicate that the same susceptibility gene lying within PSORS9 likely plays a role in both European and Chinese families of psoriasis (Bowcock, 2004; Sagoo et al., 2004) , it also suggested that the gene is expected to play only a very minor role in European populations so that its impact on disease susceptibility can only be detected using an extremely large sample such as through meta analysis. In contrast, the gene is likely to play a much stronger role in the Chinese population as indicated by our previous genome-wide scan and current follow-up analysis. Furthermore, our results strongly suggest that future study of PSORS9 should focus on early-onset patients of psoriasis, at least in the Chinese population.
We have refined the likely location of the underlying susceptibility gene to a small region at 4q31.2-32.1. The estimated location of the underlying susceptibility gene within the PSORS9 locus from using different sample sets and different methods is very consistent and indicates a much smaller critical region at 4q31.2-32.1 than previously suggested (Bowcock, 2004) . There are 65 genes annotated within the defined critical region of the PSORS9 locus, several of which are plausible candidate genes for psoriasis such as IL-15 and MGST2. IL-15 is a cytokine that triggers inflammatory cell recruitment, angiogenesis, and production of other inflammatory cytokines (Villadsen et al., 2003) and has long been suggested as a strong candidate gene. MGST2 encodes a protein that catalyzes the conjugation of leukotriene A4 and reduced glutathione to produce leukotriene C4, a competent immunomodulator (Jakobsson et al., 1996) . Two recent molecular genetic studies provided supporting evidence for MGST2 to be involved in the pathogenesis of psoriasis (Tzschach et al., 2006; Yan et al., 2006) , but our recent genetic association analysis of MGST2 in the Chinese population did not provide supporting evidence for its role in the susceptibility to psoriasis (unpublished data).
Up to today, no susceptible genes have been identified within the PSORS9 locus.
In conclusion, our follow-up analysis of the PSORS9 locus has confirmed our original linkage finding at the PSORS9 locus and refined the linkage to a small region at 4q31.2-32.1, providing much improved mapping information for future identification of the underlying susceptibility gene. Furthermore, the results of the AAO-based OSA analysis further demonstrated that the evidence for linkage is concentrated in the families of early-onset psoriasis and thus suggest that further genetic analysis of the PRORS9 locus should focus on early-onset patients, at least in the Chinese population. Together with other linkage findings at the PSORS9, our results further suggested that Chinese and European populations are likely different in terms of the involvement of the disease gene of the PSORS9 locus in susceptibility to psoriasis, which may partially explain the suggested influence of ethnic factors on prevalence of psoriasis (Christophers, 2001 ).
MATERIALS AND METHODS
Subjects
A total of 151 Chinese families with psoriasis, including 61 families used in our previous genome-wide linkage study and 90 new families, were analyzed in this follow-up study. All the families were recruited from the Dermatology Department of the Anhui Medical University using an ascertainment procedure described previously (Zhang et al., 2002) and were summarized in Table 2 . Briefly, the present family sample includes 759 individuals, 404 of which are affected (227 males and 177 females) and 354 of which are unaffected (151 males and 203 females). All the families have at least two affected siblings with an average of 2.7 affected siblings per family. All the participating individuals provided informed written consent. The study was approved by the Ethics Committee of the Anhui Medical University and was conducted according to the Declaration of Helsinki Principles.
Genotyping
Genomic DNA was extracted from peripheral blood leukocytes by standard procedures (Miller et al., 1988) . The primer sequences, expected alleles, and allele frequencies of 13 microsatellite markers studied here were obtained from the UniSTS Database (http:// www.ncbi.nlm.nih.gov/genome/sts/). All the markers were genotyped using a procedure described previously (Chen et al., 2005) . Briefly, PCR amplifications of microsatellite markers were performed in uniplex condition, and PCR products were pooled together and analyzed on an automated ABI PRISM 3730 DNA sequencer (Applied Biosystems, Foster City, CA). GeneMapper 3.0 software (Applied Biosystems) was used for determining genotypes that were further reviewed by two persons independently. All the genotypes were examined for Mendelian inconsistencies by PedCheck (O'Connell and Weeks, 1998) and double-recombinations by Merlin (Abecasis et al., 2002) . Problematic genotypes were re-typed for confirmation. When a problematic genotype could not be resolved by re-typing analysis the genotype as well as the related genotypes of family members was removed from further analysis. About 1% of the genotypes were set to be missing owing to unsolved problematic genotypes.
Statistical analysis
We performed both parametric and nonparametric linkage analyses using GENEHUNTER 2.0 (Kruglyak et al., 1996) . For parametric linkage analysis, both homogeneity and heterogeneity LOD scores were calculated by using the same genetic model as the one used in our previous genome-wide linkage analysis: dominant inheritance of a disease allele with a population frequency of 0.00062 (Zhang et al., 2002) . Furthermore, in order to reduce the adverse impact of nonpenetrant disease alleles on linkage results, parametric analysis was performed using an ''affected-only'' approach in which all normal individuals were treated as ''unknown'' instead of ''unaffected''. For nonparametric linkage analysis an NPL score was calculated using S all statistics that is more powerful than S pair statistics by capturing allele sharing information between all affected individuals within a pedigree (Kruglyak et al., 1996) .
To evaluate whether AAO is a surrogate marker of genetic heterogeneity for psoriasis, we performed an OSA using the mean AAO of each family as the covariate and the procedure proposed by Hauser et al. (2004) . Briefly, the OSA we performed goes as follows. The 151 families were first ranked according to their mean AAOs from youngest to oldest. Starting with the family with the smallest mean AAO, we formed subsets of families by adding families one at a time in the order induced by the ranks of the families. Thus, a total of 151 subsets were formed, the first one consisting of only the family with the smallest mean AAO, the second one consisting of the two families with the smallest and the second smallest mean AAO, and so on. For each subset of families, the family-specific location LOD vectors were summed and maximized over the putative positions of the disease gene. We refer to the maximum of the location LOD obtained for each subset as the ''OSA-LOD score''. The subset with the highest OSA-LOD score was then identified along with its member families. The OSA-LOD score of the largest subset, Families used in our previous genome-wide linkage analysis (Zhang et al., 2002) . that is, the one consisting of all 151 families, was taken as the baseline OSA-LOD score. The difference between the highest OSA-LOD score and the baseline OSA-LOD score was taken as the test statistics. The significance of the impact of AAO was then tested by using the test statistics and a permutation procedure (1,000 permutations). A significant impact of AAO implies that the identified subset has a significantly larger OSA-LOD score than the baseline OSA-LOD score. Finally, multipoint parametric and nonparametric analyses were performed using the identified subset of families.
